Marta Dabros

Person

Foster City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 12,172,994
- Issue date Dec 24, 2024
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 11,814,377
- Issue date Nov 14, 2023
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitor compound
- Patent number 11,160,810
- Issue date Nov 2, 2021
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,968,205
- Issue date Apr 6, 2021
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,913,740
- Issue date Feb 9, 2021
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,538,513
- Issue date Jan 21, 2020
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitor compound
- Patent number 10,493,077
- Issue date Dec 3, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,392,368
- Issue date Aug 27, 2019
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 10,308,646
- Issue date Jun 4, 2019
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of a JAK inhibitor compound
- Patent number 10,251,874
- Issue date Apr 9, 2019
- Theravance Biopharma R&D IP, LLC
- Marta Dabros
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,183,942
- Issue date Jan 22, 2019
- Theravance Biopharma R&D IP, LLC
- Noah Benjamin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of a factor XIa inhibitor
- Patent number 9,920,034
- Issue date Mar 20, 2018
- Bristol-Myers Squibb Company
- Marta Dabros
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydronaphthalenyl compounds useful as sipi agonists
- Patent number 9,115,054
- Issue date Aug 25, 2015
- Bristol-Myers Squibb Company
- T. G. Murali Dhar
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
POLYMORPHS OF BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AND U...
- Publication number 20230357167
- Publication date Nov 9, 2023
- Bristol-Myers Squibb Company
- Marta DABROS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORM OF A DIHYDROCHLORIDE SALT OF A JAK INHIBITOR COMPOUND
- Publication number 20220306626
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Jerry Nzerem
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20220119369
- Publication date Apr 21, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE ALK5 INHIBITORS AND USES THEREOF
- Publication number 20210387983
- Publication date Dec 16, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Alec Brozell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20200216423
- Publication date Jul 9, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20200087303
- Publication date Mar 19, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
- Publication number 20200046719
- Publication date Feb 13, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20190315724
- Publication date Oct 17, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20190127364
- Publication date May 2, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20190040043
- Publication date Feb 7, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- ERIK FENSTER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20180319796
- Publication date Nov 8, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Noah Benjamin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND
- Publication number 20180311223
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- MARTA DABROS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
- Publication number 20180311255
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20170121327
- Publication date May 4, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS
- Publication number 20160318904
- Publication date Nov 3, 2016
- Bristol-Myers Squibb Company
- Michael J. Orwat
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A FACTOR XIA INHIBITOR
- Publication number 20150266855
- Publication date Sep 24, 2015
- BRISTOL-MYERS SQUIBB COMPANY
- Marta Dabros
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC COMPOUNDS
- Publication number 20140235591
- Publication date Aug 21, 2014
- T. G. Murali Dhar
- C07 - ORGANIC CHEMISTRY

Marta Dabros

Person

Patents Grantslast 30 patents

Pyrimidine compound as JAK kinase inhibitor

Pyrimidine compound as JAK kinase inhibitor

JAK kinase inhibitor compounds for treatment of respiratory disease

Fused imidazo-piperidine JAK inhibitor compound

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

JAK kinase inhibitor compounds for treatment of respiratory disease

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Fused imidazo-piperidine JAK inhibitor compound

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Pyrimidine compound as JAK kinase inhibitor

Crystalline forms of a JAK inhibitor compound

JAK kinase inhibitor compounds for treatment of respiratory disease

Crystalline forms of a factor XIa inhibitor

Tetrahydronaphthalenyl compounds useful as sipi agonists

Patents Applicationslast 30 patents

POLYMORPHS OF BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AND U...

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

CRYSTALLINE FORM OF A DIHYDROCHLORIDE SALT OF A JAK INHIBITOR COMPOUND

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

CRYSTALLINE ALK5 INHIBITORS AND USES THEREOF

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS

CRYSTALLINE FORMS OF A FACTOR XIA INHIBITOR

BICYCLIC COMPOUNDS